Chemical Engineering
Walid Saad is an associate professor of chemical engineering at the American University of Beirut (AUB). Prior to joining AUB in 2010, Walid assumed the position of senior scientist at Merck, New Jersey, USA. Over a period of over three years, he worked on cancer drug development. While in this role, he provided support for the successful filing and regulatory approval of the brain tumor treatment drug Temozolomide Powder For Injection 100 mg/vial in the US, Canada, and Europe. Prior to his involvement in the pharmaceutical industry, Walid obtained his Ph.D. in chemical engineering from Princeton University, working with Prof. Robert Prud’homme on nanotechnology-based drug formulations. Walid’s current research interests are focused on nanotechnology, pharmaceuticals, and the environment. Walid holds a B.S. in chemical engineering from the University of Minnesota, and a B.S. in chemistry from the Lebanese American University in Beirut.